Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 20863759

Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Oncol
Publication date
2010 Oct
First author
Krag DN

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2010 Oct;11(10):908-9. doi: 10.1016/S1470-2045(10)70220-5.
    note
    Source null
    related pmid
    20863762
    relationship
    Comment in

Authors and identifiers

  1. name
    Krag DN
    type
    Author
  2. name
    Anderson SJ
    type
    Author
  3. name
    Julian TB
    type
    Author
  4. name
    Brown AM
    type
    Author
  5. name
    Harlow SP
    type
    Author
  6. name
    Costantino JP
    type
    Author
  7. name
    Ashikaga T
    type
    Author
  8. name
    Weaver DL
    type
    Author
  9. name
    Mamounas EP
    type
    Author
  10. name
    Jalovec LM
    type
    Author
  11. name
    Frazier TG
    type
    Author
  12. name
    Noyes RD
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Krag DN
    type
    Author
  2. name
    Anderson SJ
    type
    Author
  3. name
    Julian TB
    type
    Author
  4. name
    Brown AM
    type
    Author
  5. name
    Harlow SP
    type
    Author
  6. name
    Costantino JP
    type
    Author
  7. name
    Ashikaga T
    type
    Author
  8. name
    Weaver DL
    type
    Author
  9. name
    Mamounas EP
    type
    Author
  10. name
    Jalovec LM
    type
    Author
  11. name
    Frazier TG
    type
    Author
  12. name
    Noyes RD
    type
    Author
bibliography ids
  1. nci-bib-61563d560a28582a94c11c17
book metadata
content sha256
360a9510fd7906212a5d9ee393471c1b6f4a00280f14aeed3a54863190517449
document type
citation
dois
  1. 10.1016/S1470-2045(10)70207-2
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:20863759
immutable id
pubmed:20863759@360a9510fd7906212a5d9ee393471c1b6f4a00280f14aeed3a54863190517449
journal
abbreviation
Lancet Oncol
issn electronic
1474-5488
issn print
1470-2045
issue
10
name
The Lancet. Oncology
nlm unique id
100957246
pages
927-33
volume
11
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2010 Oct;11(10):908-9. doi: 10.1016/S1470-2045(10)70220-5.
    note
    Source null
    related pmid
    20863762
    relationship
    Comment in
outcomes validated
false
pmid
20863759
provenance
batch id
10a38257e12e9ed1867a
provider
NCBI PubMed ESummary
record sha256
c448e1bb3c4fd1b516b68f8f07adaade3fe7bcfcf3b7aac5c14c89350bbc7d16
response sha256
84c4808ca38b35d999cfdf809eb088835175ab38d71586c626096d677096bbcc
retrieved at
2026-09-09T23:46:35.793530+00:00
publication date
display
2010 Oct
precision
month
year
2010
publication types
  1. Clinical Trial, Phase III
  2. Comparative Study
  3. Journal Article
  4. Multicenter Study
  5. Randomized Controlled Trial
  6. Research Support, N.I.H., Extramural
  7. Research Support, Non-U.S. Gov't
  8. Research Support, U.S. Gov't, P.H.S.
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/20863759/
title
Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial.

Preserved source evidence · Not medical advice